DR. JOHN P FLANAGAN M.D. NPI 1326097106

NPI Details

DR. John P Flanagan, M.D. is a family medicine in Grand Junction, CO with 31 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. John P Flanagan, M.D. NPI is 1326097106. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE
Graduation Year:1994

The provider's business location address is:

3150 N 12TH ST
GRAND JUNCTION, CO
ZIP 81506-863
Phone: (970) 245-1220
Fax: (970) 245-9148

The NPI 1326097106 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
• Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Blood test, clotting time (HCPCS:85610)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• X-ray of chest, 2 views (HCPCS:71046)
• Screening 3d breast mammography (HCPCS:77063)
• Screening mammography (HCPCS:77067)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Ldl cholesterol level (HCPCS:83721)
• Automated urinalysis test (HCPCS:81003)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Vitamin d-3 level (HCPCS:82306)
• Administration of vaccine (HCPCS:90471)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 5/9/2006 and was last updated on 10/16/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: